Inovalon Holdings Company Profile (NASDAQ:INOV)

About Inovalon Holdings (NASDAQ:INOV)

Inovalon Holdings logoInovalon Holdings, Inc. (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. The Company serves clients across the healthcare industry, which includes health plans and provider organizations, pharmaceutical, medical device, and diagnostics companies. It provides technology that supports approximately 500 healthcare organizations. Inovalon's platforms are informed by data pertaining to more than 856,000 physicians, 375,000 clinical facilities, and more than 158 million Americans.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: IT Services & Consulting - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:INOV
  • CUSIP: N/A
  • Web:
  • Market Cap: $1.932 billion
  • Outstanding Shares: 63,314,000
Average Prices:
  • 50 Day Moving Avg: $13.10
  • 200 Day Moving Avg: $12.64
  • 52 Week Range: $8.60 - $16.64
  • Trailing P/E Ratio: 112.61
  • Foreward P/E Ratio: 43.23
  • P/E Growth: 5.34
Sales & Book Value:
  • Annual Revenue: $419.99 million
  • Price / Sales: 2.02
  • Book Value: $4.49 per share
  • Price / Book: 2.98
  • EBIDTA: $67.35 million
  • Net Margins: 4.13%
  • Return on Equity: 5.17%
  • Return on Assets: 3.38%
  • Debt-to-Equity Ratio: 0.33%
  • Current Ratio: 6.48%
  • Quick Ratio: 6.48%
  • Average Volume: 571,377 shs.
  • Beta: 1.19
  • Short Ratio: 15.35
Frequently Asked Questions for Inovalon Holdings (NASDAQ:INOV)

What is Inovalon Holdings' stock symbol?

Inovalon Holdings trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon Holdings' earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) issued its earnings results on Wednesday, August, 2nd. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.01. The firm had revenue of $110.60 million for the quarter, compared to analysts' expectations of $108.73 million. Inovalon Holdings had a net margin of 4.13% and a return on equity of 5.17%. The business's revenue was down 10.7% on a year-over-year basis. During the same quarter last year, the business earned $0.14 earnings per share. View Inovalon Holdings' Earnings History.

When will Inovalon Holdings make its next earnings announcement?

Inovalon Holdings is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Inovalon Holdings.

What guidance has Inovalon Holdings issued on next quarter's earnings?

Inovalon Holdings updated its FY17 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of $0.29-$0.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.30. The company issued revenue guidance of $447.1-$459.3 million, compared to the consensus revenue estimate of $445.79 million.

Where is Inovalon Holdings' stock going? Where will Inovalon Holdings' stock price be in 2017?

6 analysts have issued 1-year price objectives for Inovalon Holdings' stock. Their predictions range from $10.00 to $20.00. On average, they anticipate Inovalon Holdings' share price to reach $14.00 in the next year. View Analyst Ratings for Inovalon Holdings.

Who are some of Inovalon Holdings' key competitors?

Who are Inovalon Holdings' key executives?

Inovalon Holdings' management team includes the folowing people:

  • Keith R. Dunleavy M.D., Chairman of the Board, Chief Executive Officer
  • Robert A. Wychulis, President
  • Christopher E. Greiner, Chief Financial Officer, Chief Operating Officer
  • Daniel N. Mendelson, President of Avalere Health
  • Christopher Hand, Chief Growth Officer
  • Shauna L. Vernal, Chief Legal Officer, Corporate Secretary
  • Denise K. Fletcher, Independent Director
  • William D. Green, Independent Director
  • Andre S. Hoffmann, Independent Director
  • Lee D. Roberts, Independent Director

When did Inovalon Holdings IPO?

(INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Who owns Inovalon Holdings stock?

Inovalon Holdings' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Black Creek Investment Management Inc. (17.26%), Vanguard Group Inc. (3.48%), Bamco Inc. NY (5.47%), Riverbridge Partners LLC (4.97%), Neuberger Berman Group LLC (1.33%) and State Street Corp (1.82%). Company insiders that own Inovalon Holdings stock include Christopher E Greiner, Daniel L Rizzo, Joseph R Rostock, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, Shauna L Vernal, Thomas R Kloster, William D Green and William J Teuber Jr. View Institutional Ownership Trends for Inovalon Holdings.

Who sold Inovalon Holdings stock? Who is selling Inovalon Holdings stock?

Inovalon Holdings' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bamco Inc. NY, Parametric Portfolio Associates LLC, First Quadrant L P CA, Adirondack Research & Management Inc., Riverbridge Partners LLC, New York State Common Retirement Fund and Neuberger Berman Group LLC. Company insiders that have sold Inovalon Holdings stock in the last year include Joseph R Rostock, Shauna L Vernal and Thomas R Kloster. View Insider Buying and Selling for Inovalon Holdings.

Who bought Inovalon Holdings stock? Who is buying Inovalon Holdings stock?

Inovalon Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Black Creek Investment Management Inc., State Street Corp, Koch Industries Inc., Vanguard Group Inc., Schwab Charles Investment Management Inc., Senvest Management LLC, GSA Capital Partners LLP and Alliancebernstein L.P.. Company insiders that have bought Inovalon Holdings stock in the last two years include Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, William D Green and William J Teuber Jr. View Insider Buying and Selling for Inovalon Holdings.

How do I buy Inovalon Holdings stock?

Shares of Inovalon Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inovalon Holdings' stock price today?

One share of Inovalon Holdings stock can currently be purchased for approximately $13.40.

MarketBeat Community Rating for Inovalon Holdings (NASDAQ INOV)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  226
MarketBeat's community ratings are surveys of what our community members think about Inovalon Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Inovalon Holdings (NASDAQ:INOV) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $14.00 (4.48% upside)

Analysts' Ratings History for Inovalon Holdings (NASDAQ:INOV)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/16/2017Robert W. BairdReiterated RatingNeutral$11.00 -> $12.00LowView Rating Details
2/23/2017William BlairReiterated RatingMarket PerformN/AView Rating Details
2/13/2017Bank of America CorporationDowngradeNeutral -> Underperform$10.00N/AView Rating Details
12/13/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/4/2016Pacific CrestSet Price TargetBuy$20.00N/AView Rating Details
10/24/2016First AnalysisInitiated CoverageEqual -> Equal Weight$14.00N/AView Rating Details
8/16/2016KeyCorpLower Price TargetOverweight$26.00 -> $20.00N/AView Rating Details
8/4/2016Citigroup Inc.Lower Price TargetNeutral$18.00 -> $17.00N/AView Rating Details
8/4/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$25.00 -> $17.00N/AView Rating Details
8/4/2016Piper Jaffray CompaniesDowngradeNeutral -> Underweight$14.00 -> $11.00N/AView Rating Details
5/8/2016Morgan StanleyReiterated RatingSell$16.00N/AView Rating Details
(Data available from 8/17/2015 forward)


Earnings History for Inovalon Holdings (NASDAQ:INOV)
Earnings by Quarter for Inovalon Holdings (NASDAQ:INOV)
Earnings History by Quarter for Inovalon Holdings (NASDAQ INOV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017N/AView Earnings Details
8/2/2017Q2 2017$0.07$0.08$108.73 million$110.60 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.05$0.05$102.05 million$108.31 millionViewListenView Earnings Details
2/22/2017Q4 2016$0.03$0.05$95.10 million$96.09 millionViewListenView Earnings Details
11/2/2016Q316$0.06$0.10$102.38 million$105.01 millionViewListenView Earnings Details
8/3/2016Q2$0.14$0.14$126.86 million$123.80 millionViewListenView Earnings Details
5/4/2016Q116$0.08$0.05$97.96 million$102.70 millionViewN/AView Earnings Details
2/25/2016Q4$0.13$0.13$125.40 million$120.60 millionViewListenView Earnings Details
11/4/2015Q315$0.09$0.09$102.76 million$105.46 millionViewN/AView Earnings Details
8/5/2015Q215$0.18$0.17$122.06 million$117.62 millionViewListenView Earnings Details
5/6/2015Q115$0.09$0.11$91.00 million$93.60 millionViewListenView Earnings Details
3/25/2015Q414$0.11$0.11$89.20 million$89.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Inovalon Holdings (NASDAQ:INOV)
2017 EPS Consensus Estimate: $0.31
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.01$0.04$0.03
Q2 20172$0.06$0.06$0.06
Q3 20173$0.07$0.17$0.11
Q4 20173$0.07$0.20$0.12
Q2 20181$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Dividend History for Inovalon Holdings (NASDAQ:INOV)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Inovalon Holdings (NASDAQ:INOV)
Insider Ownership Percentage: 48.28%
Institutional Ownership Percentage: 29.52%
Insider Trades by Quarter for Inovalon Holdings (NASDAQ:INOV)
Institutional Ownership by Quarter for Inovalon Holdings (NASDAQ:INOV)
Insider Trades by Quarter for Inovalon Holdings (NASDAQ:INOV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2017Shauna L VernalInsiderSell19,332$13.60$262,915.20View SEC Filing  
5/8/2017Joseph R RostockInsiderSell104,649$13.07$1,367,762.43View SEC Filing  
5/5/2017Keith R DunleavyCEOBuy40,000$12.98$519,200.00View SEC Filing  
12/16/2016Robert A WychulisPresidentBuy1,675$9.29$15,560.75View SEC Filing  
12/16/2016William D GreenDirectorBuy30,000$9.29$278,700.00View SEC Filing  
12/14/2016Keith R DunleavyCEOBuy100,000$9.21$921,000.00View SEC Filing  
11/11/2016Thomas R KlosterCFOSell109,899$15.53$1,706,731.47View SEC Filing  
9/16/2016William D GreenDirectorBuy30,000$16.22$486,600.00View SEC Filing  
9/8/2016William J Teuber JrDirectorBuy60,000$16.46$987,600.00View SEC Filing  
7/12/2016Daniel L RizzoInsiderSell43,577$20.02$872,411.54View SEC Filing  
5/9/2016Keith R DunleavyCEOBuy30,000$16.68$500,400.00View SEC Filing  
3/4/2016Robert A WychulisPresidentSell33,003$18.17$599,664.51View SEC Filing  
12/9/2015Daniel L RizzoInsiderSell24,000$20.00$480,000.00View SEC Filing  
12/4/2015Shauna L. VernalinsiderSell33,437$18.55$620,256.35View SEC Filing  
8/28/2015Christopher E. GreinerCOOSell124,813$21.20$2,646,035.60View SEC Filing  
8/28/2015Keith R. DunleavyCEOBuy50,000$21.30$1,065,000.00View SEC Filing  
8/27/2015Lee D. RobertsDirectorBuy24,000$21.05$505,200.00View SEC Filing  
2/18/2015Shauna L VernalInsiderBuy10,000$27.00$270,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Inovalon Holdings (NASDAQ:INOV)
Latest Headlines for Inovalon Holdings (NASDAQ:INOV)
DateHeadline logoInovalon Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INOV-US : August 15, 2017 - August 16 at 1:30 AM logoSee what the IHS Markit Score report has to say about Inovalon Holdings Inc. - August 14 at 10:47 PM logoInovalon Holdings, Inc. (NASDAQ:INOV) Lowered to Hold at BidaskClub - August 13 at 10:04 AM logoInovalon Holdings Inc - August 11 at 4:11 AM logoIHS Markit Score downgrades Inovalon Holdings Inc to 32 out of 100, ranking negatively in one out of three available IHS Markit categories. - August 11 at 4:11 AM logo$114.50 Million in Sales Expected for Inovalon Holdings, Inc. (INOV) This Quarter - August 9 at 7:24 AM logoInovalon Certified by CMS, Receiving Fee-For-Service Medicare Data for All 50 States and the District of Columbia - August 8 at 7:34 PM logoInovalon Holdings, Inc. Forecasted to Earn Q2 2018 Earnings of $0.10 Per Share (NASDAQ:INOV) - August 8 at 11:08 AM logo$0.07 Earnings Per Share Expected for Inovalon Holdings, Inc. (NASDAQ:INOV) This Quarter - August 7 at 12:12 PM logoInovalon Holdings, Inc. Forecasted to Post Q3 2017 Earnings of $0.07 Per Share (NASDAQ:INOV) - August 7 at 7:40 AM logoInovalon Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INOV-US : August 4, 2017 - August 4 at 8:09 PM logoEdited Transcript of INOV earnings conference call or presentation 2-Aug-17 9:00pm GMT - August 3 at 8:03 PM logoInovalon Holdings beats Street 2Q forecasts - August 3 at 8:03 PM logoInovalon Holdings, Inc. (NASDAQ:INOV) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - August 3 at 12:44 AM logoBRIEF-Inovalon Holdings Q2 EPS $0.04 - August 2 at 11:33 PM logoInovalon Reports Second Quarter 2017 Results - August 2 at 11:33 PM logoInovalon Holdings, Inc. (NASDAQ:INOV) Issues FY17 Earnings Guidance - August 2 at 6:46 PM logoInovalon Holdings, Inc. (NASDAQ:INOV) Receives Average Rating of "Hold" from Brokerages - July 25 at 11:11 AM logoInovalon Holdings, Inc. (NASDAQ:INOV) Expected to Post Quarterly Sales of $109.35 Million - July 20 at 1:28 PM logoInovalon Announces Second Quarter 2017 Earnings Conference Call - July 19 at 10:15 PM logoHarwood Feffer LLP Announces Investigation of Inovalon Holdings, Inc. - July 18 at 10:35 PM logoInovalon Holdings, Inc. (INOV) Expected to Announce Earnings of $0.06 Per Share - July 18 at 12:13 PM logoNational Health Plans Select Inovalon’s Integrated Platform - July 18 at 2:21 AM logoInovalon Holdings, Inc. – Value Analysis (NASDAQ:INOV) : July 7, 2017 - July 8 at 11:46 AM logoInovalon Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INOV-US : July 6, 2017 - July 7 at 6:28 AM logoInovalon Holdings, Inc. (INOV) Given Consensus Rating of "Hold" by Analysts - June 30 at 12:16 PM logo$109.35 Million in Sales Expected for Inovalon Holdings Inc (INOV) This Quarter - June 24 at 10:40 AM logoInovalon Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INOV-US : June 22, 2017 - June 22 at 1:10 PM logo Analysts Expect Inovalon Holdings, Inc. (INOV) to Post $0.06 EPS - June 22 at 8:16 AM logoRobert W. Baird Reiterates Neutral Rating for Inovalon Holdings, Inc. (INOV) - June 16 at 7:00 PM logoETFs with exposure to Inovalon Holdings, Inc. : June 13, 2017 - June 13 at 5:44 PM logoBowie health tech firm Inovalon to lay off 113 employees - June 13 at 5:44 PM logoInovalon Holdings Inc (INOV) Upgraded by BidaskClub to Strong-Buy - June 10 at 7:58 PM logoHaeggquist & Eck, LLP Announces Investigation Concerning Inovalon Holdings, Inc. Regarding Potential Breaches of Fiduciary Duty by Executives - June 9 at 9:38 AM logoCommit To Purchase Inovalon Holdings At $12.50, Earn 14.9% Annualized Using Options - June 8 at 6:52 PM logoNew Study: Physicians Lack the Right Tools to Close Costly Gaps in Healthcare - June 6 at 11:34 AM logoInovalon Holdings Inc (INOV) Receives Average Rating of "Hold" from Brokerages - June 5 at 9:15 AM logoETFs with exposure to Inovalon Holdings, Inc. : June 2, 2017 - June 2 at 7:22 PM logoInovalon Holdings, Inc. :INOV-US: Earnings Analysis: Q1, 2017 By the Numbers : June 1, 2017 - June 1 at 3:16 PM logoZacks: Brokerages Expect Inovalon Holdings Inc (INOV) Will Post Quarterly Sales of $109.35 Million - May 28 at 7:28 AM logoZacks: Analysts Anticipate Inovalon Holdings Inc (INOV) Will Post Earnings of $0.06 Per Share - May 27 at 12:34 AM logoInovalon Holdings Inc (INOV) Insider Shauna L. Vernal Sells 19,332 Shares - May 24 at 8:04 PM logoVanguard Health Care Fund Buys Abbott Laboratories, Tesaro Inc, Teva Pharmaceutical Industries, ... - May 17 at 9:57 AM logoShort Interest in Inovalon Holdings Inc (INOV) Drops By 1.5% - May 12 at 7:22 AM logoJoseph R. Rostock Sells 104,649 Shares of Inovalon Holdings Inc (INOV) Stock - May 9 at 4:37 PM logoInovalon Holdings Inc (INOV) Receives Consensus Recommendation of "Hold" from Analysts - May 9 at 9:25 AM logoKeith R. Dunleavy Buys 40,000 Shares of Inovalon Holdings Inc (INOV) Stock - May 8 at 1:40 PM logoKeyCorp Weighs in on Inovalon Holdings Inc's FY2018 Earnings (INOV) - May 8 at 11:56 AM logoQ2 2017 Earnings Forecast for Inovalon Holdings Inc Issued By William Blair (INOV) - May 8 at 8:15 AM logoInovalon Holdings Inc (INOV) Downgraded by Zacks Investment Research to "Hold" - May 6 at 12:36 AM



Inovalon Holdings (INOV) Chart for Thursday, August, 17, 2017

This page was last updated on 8/17/2017 by Staff